These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Noninvasive cardiac evaluation of patients receiving adriamycin. Ewy GA; Jones SE; Friedman MJ; Gaines J; Cruze D Cancer Treat Rep; 1978 Jun; 62(6):915-22. PubMed ID: 667868 [No Abstract] [Full Text] [Related]
6. [Echocardiography with angiotensin administration in the diagnosis of adriamycin-induced cardiomyopathy]. Göldel N; Autenrieth G; Werdan K; Knesewitsch P; Wilmanns W Z Kardiol; 1989 May; 78(5):320-7. PubMed ID: 2735093 [TBL] [Abstract][Full Text] [Related]
7. Studies on adriamycin using a weekly regimen demonstrating its clinical effectiveness and lack of cardiac toxicity. Weiss AJ; Metter GE; Fletcher WS; Wilson WL; Grage TB; Ramirez G Cancer Treat Rep; 1976 Jul; 60(7):813-22. PubMed ID: 795537 [TBL] [Abstract][Full Text] [Related]
8. Cardiotoxicity in children treated with anthracyclines: the role of M-mode echocardiography. Galli MA; Conter V; Zanetto F; Jankovic M; Ferrari L; Baio G; Masera G Haematologica; 1987; 72(4):347-50. PubMed ID: 3117636 [No Abstract] [Full Text] [Related]
9. Effect of a 1-hour IV infusion of doxorubicin on the development of cardiotoxicity in dogs as evaluated by electrocardiography and echocardiography. Gillings S; Johnson J; Fulmer A; Hauck M Vet Ther; 2009; 10(1-2):46-58. PubMed ID: 19742448 [TBL] [Abstract][Full Text] [Related]
10. [The significance of notches or bites in the vectorcardiogram. Study in cardiopathy caused by adriamycin]. Vitolo E; Madoi S; Roveda M; Larovere MT; Beretta G; Obbiassi M Boll Soc Ital Cardiol; 1980; 25(9):1073-5. PubMed ID: 7284195 [No Abstract] [Full Text] [Related]
12. [Is the use of adriamycin (doxorubicin) limited by its cardiotoxicity?]. Reinhardt D; Hofmann V; Martz G Schweiz Med Wochenschr; 1985 Apr; 115(16):557-61. PubMed ID: 4001904 [TBL] [Abstract][Full Text] [Related]